News & Events

News &
Events

Tarsier Pharma Announces Presentation at the AAO Annual Meeting 2024

October 18-21, 2024

Tarsier Pharma, Ltd will attend in the upcoming American Academy of Ophthalmology (AAO) Annual Meeting, taking place on October 18-21, 2024, at McCormick Place in Chicago.

Dr. David S Chu, MD, present groundbreaking research on “Dazdotuftide: A New Steroid-Free Treatment for Non-infectious Anterior Uveitis with a Superior IOP Safety Profile”. This research highlights the potential of Dazdotuftide to revolutionize the standard of care for patients suffering from non-infectious anterior uveitis.

Presentation Details:
Presentation Title: Dazdotuftide: A New Steroid-Free Treatment for Non-infectious Anterior Uveitis with a Superior IOP Safety Profile
Date: Saturday, October 19, 2024
Time: 10:30 AM to 11:30 AM
Location: Hall A in the Poster Theater

 

About Tarsier Pharma

Tarsier Pharma is a clinical stage biopharmaceutical company, focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat immune-mediated blinding diseases in the front and back of the eye.

 

Contact:

Investor Relations Tarsier Pharma

[email protected]

 

Scroll to Top